DermaFlow
Medical Devices - Cherry Hill, New Jersey, United States
DermaFlow Details
DermaFlow has developed a non-invasive proprietary and patented technology that accurately and cost effectively measures directly peripheral (in the capillaries) blood flow and detects tell-tale changes in microcirculation. It has been estimated that ~ 90% of disease results in microcirculation changes, and therefore having a "friendly" and affordable way to monitor this routinely is of significant value to modern healthcare.This technology lends itself easily and expediently to three major healthcare trends:*stream-lined 510 K predicate regulatory track designated (for a stand-alone device)* wireless monitoring for home and remote situations* integration into existing monitoring and/or sensing devicesDermaFlow has completed early proof-of-concept clinical studies, and is focusing currently on acute care (sepsis in ICU patients) with its first stand alone product Perichek Multi.In addition, Dermaflow has completed development of Perichek - a module suitable for integration into established patient monitoring suites.Dermaflow technology has a wide range of applications in acute and chronic care, both in and out of hospital.We welcome interested corporate, clinical, and strategic partners as well as accredited investors.
DermaFlow Technologies
Email Providers
Gmail
Fonts
Typekit
Tag Management
Google Tag Manager
Other
Google Apps
Online Video Platforms
Vimeo